These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24361625)

  • 1. Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.
    Modi S; Chiu A; Ng'eno B; Kellerman SE; Sugandhi N; Muhe L;
    AIDS; 2013 Nov; 27 Suppl 2(0 2):S159-67. PubMed ID: 24361625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
    Lawn SD; Harries AD; Wood R
    Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis.
    B-Lajoie MR; Drouin O; Bartlett G; Nguyen Q; Low A; Gavriilidis G; Easterbrook P; Muhe L
    Clin Infect Dis; 2016 Jun; 62(12):1586-1594. PubMed ID: 27001796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections and other causes of death in HIV-infected children in Africa.
    Chakraborty R
    Paediatr Respir Rev; 2004 Jun; 5(2):132-9. PubMed ID: 15135123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Frigati L; Archary M; Rabie H; Penazzato M; Ford N
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S147-S151. PubMed ID: 29514237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.
    Little K; Thorne C; Luo C; Bunders M; Ngongo N; McDermott P; Newell ML
    Curr HIV Res; 2007 Mar; 5(2):139-53. PubMed ID: 17346131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
    Zachariah R; Harries AD; Luo C; Bachman G; Graham SM
    Lancet Infect Dis; 2007 Oct; 7(10):686-93. PubMed ID: 17897611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa.
    Jesson J; Leroy V
    Med Mal Infect; 2015 May; 45(5):149-56. PubMed ID: 25861689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced HIV disease: A review of diagnostic and prophylactic strategies.
    Lehman A; Ellis J; Nalintya E; Bahr NC; Loyse A; Rajasingham R
    HIV Med; 2023 Aug; 24(8):859-876. PubMed ID: 37041113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing HIV Treatment Access and Outcomes Amongst HIV Infected Children and Adolescents in Resource Limited Settings.
    Goga AE; Singh Y; Singh M; Noveve N; Magasana V; Ramraj T; Abdullah F; Coovadia AH; Bhardwaj S; Sherman GG
    Matern Child Health J; 2017 Jan; 21(1):1-8. PubMed ID: 27514391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of health programmes to prevent vertical transmission of HIV. Advances, emerging health challenges and research priorities for children exposed to or living with HIV: Perspectives from South Africa.
    Goga A; Slogrove A; Wedderburn CJ; Feucht U; Wessels J; Ramokolo V; Bhana A; Du Plessis N; Green RJ; Pillay Y; Sherman G
    S Afr Med J; 2019 Dec; 109(11b):77-82. PubMed ID: 32252873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV testing for children in resource-limited settings: what are we waiting for?
    Kellerman S; Essajee S
    PLoS Med; 2010 Jul; 7(7):e1000285. PubMed ID: 20652012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infections and children].
    Baumann U
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():70-4. PubMed ID: 16385883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania.
    Letang E; Kalinjuma AV; Glass TR; Gamell A; Mapesi H; Sikalengo GR; Luwanda LB; Mnzava D; Ntamatungiro AJ; Ndaki R; Francis G; Vanobberghen F; Furrer H; Klimkait T; Felger I; Tanner M; Hatz C; Weisser M; Battegay M; Kiularco Study Group
    Swiss Med Wkly; 2017; 147():w14485. PubMed ID: 28695551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.